Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Organogenesis Holdings (NASDAQ:ORGO) through any online brokerage.
Other companies in Organogenesis Holdings’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Organogenesis Holdings has a consensus price target of $6.00.
The stock price for Organogenesis Holdings (NASDAQ: ORGO) is $1.34 last updated October 6, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Organogenesis Holdings.
Organogenesis Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Organogenesis Holdings.
Organogenesis Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.